Phase 1 HR Positive HER2 Negative Advanced Breast Cancer Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Metastatic Breast CancerAdvanced Breast CancerMetastatic Lung Cancer+8 more

TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)392 enrolled36 locationsNCT06625775

Recruiting

Phase 1Phase 2

Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors

HR Positive HER2 Negative Advanced Breast Cancer

TYK Medicines, Inc180 enrolled2 locationsNCT06950086